Iron-deficiency
Conditions
Brief summary
Despite its high prevalence, a recent study conducted by Prof. Cacoub (unpublished) on the french national health insurance database showed that iron deficiency was an underdiagnosed and under-treated co-morbidity. In inflammatory situations, especially during cancer, the measurement of the transferrin saturation factor is only performed in about 10% of cases whereas this measure is recommended in inflammatory situations including cancer (French Health High Authority 2011)
Interventions
DIAGNOSTIC_TESTIron deficiency testing
Blood sample for complete iron status
Sponsors
VIFORFRANCE
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Patient, male or female, over the age of 18 * Patient in an oncology department (any type of tumor, any type of treatment, initiated or not) * Patient affiliated or beneficiary of a social security system * Patient with written consent
Exclusion criteria
* Protected patient: major under guardianship, curatorship or other legal protection, deprived of liberty by judicial or administrative decision * Patient hospitalized without consent
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Blood iron status | One day | ferritin, haemoglobin, transferrin saturation factor |
Outcome results
None listed